• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Institute of Biomedi (OP: MRES )

    0.0037 -0.0002 (-5.13%)
    Streaming Delayed Price Updated: 3:39 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,093,203
    Open 0.0036
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0039
    Today's Range 0.0034 - 0.0047
    52wk Range 0.0027 - 0.0149
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
    Via ACCESSWIRE
    MRES: M2Bio Sciences Provides Corporate Update
    Via ACCESSWIRE

    Performance

    YTD
    -63.00%
    -63.00%
    1 Month
    -24.49%
    -24.49%
    3 Month
    -51.32%
    -51.32%
    6 Month
    -54.32%
    -54.32%
    1 Year
    -56.47%
    -56.47%

    More News

    Read More
    MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
    Via ACCESSWIRE
    MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
    Via ACCESSWIRE
    MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
    Via ACCESSWIRE
    Real American Announces Acquisition of M2MMA from MRES
    Via ACCESSWIRE
    MRES: M2MMA Gears Up for a Landmark Year in 2024
    Via ACCESSWIRE
    MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
    Via ACCESSWIRE
    MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
    Via ACCESSWIRE
    African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
    Via ACCESSWIRE
    M2MMA Announces 2024 Fight Schedule and Appoints CEO
    Via ACCESSWIRE
    M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
    Via ACCESSWIRE
    M2Bio Sciences Closes JDAX Acquisition
    Via ACCESSWIRE
    M2Bio Sciences Pharmacology & Clinical Application of CBD
    Via ACCESSWIRE
    M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
    Via ACCESSWIRE
    M2bio Sciences Announces Launch of Exclusive MMA Organization
    Via ACCESSWIRE
    BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Unveils Meticulously Crafted Line of Teas Sourced from Kenya
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
    Via Benzinga
    M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
    Via News Direct
    M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
    Via TheNewswire.com
    Innovative Holdings Alliance, Inc. Announces Brand License Agreement with M2Bio Sciences
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.